"We are always looking for cutting-edge neuroscience solutions that improve brain health, making NextSense a perfect addition to our portfolio," said Itsik Francis, PhD, Managing Partner, Business Development at Corundum Neuroscience.
). The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete ...UNITED STATES SECURITIES AND EXCHANGE COMMISSION ... 20549 ... Corundum Group, Inc ... Corundum Group Inc.
"This new venture initiative offers an exciting opportunity for Corundum to play a key role in shaping the future of life sciences and discover new ways to improve global human health," said Yasushi Yamamoto, CEO and Founder of Corundum Corp.